Medical Oncologist
Monitoring on ibrutinib
Tests and Monitoring — While You Are on Ibrutinib
Ibrutinib is a daily tablet that works continuously, which means your blood, heart and blood pressure need to be watched on a regular schedule. Most tests confirm that things are going well — knowing what each one is for makes the routine easier to keep.
Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed August 2026
- Denser at the start — Tests are more frequent in the first few months and spread out once your results are stable.
- Your heart is included — Ibrutinib can increase the chance of atrial fibrillation, so an ECG is done at baseline and repeated if symptoms appear.
- A lymphocyte rise is expected — In CLL, a temporary rise in lymphocyte count is a treatment effect, not a sign of progression.
- Tell your team about procedures — Ibrutinib is usually held before surgery or any procedure with a bleeding risk — your team needs to know in advance.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
While you are taking ibrutinib, your team will order regular blood counts, liver and kidney tests, blood pressure checks and, at baseline, an ECG. The tests are not optional extras — they catch side effects before they become serious. Most tests are done at your routine clinic visits and require only a blood draw.
Why does a once-daily tablet need so much monitoring?
Ibrutinib works continuously, not in short infusion cycles. Any effect it has on your blood, liver, kidneys or heart builds gradually — which is exactly why monitoring catches problems at the stage when they are easiest to manage.
Most people on ibrutinib have routine tests that confirm things are going well. A blood test order is not a warning sign. It is how your team stays ahead rather than reacting.
The schedule is denser in the first few months and spreads out once your results are stable.
What does the monitoring schedule look like?
Before your first dose
Your team does a baseline blood count, liver and kidney tests, and an ECG to record your starting values. Blood pressure is measured. These results set the reference point for everything that follows.
First few months on treatment
Blood counts are checked more often in this period. Blood pressure is reviewed at each clinic visit. Your team is watching for early changes to platelets, neutrophils and haemoglobin.
Ongoing routine checks
Once your results are stable, the interval between blood tests spreads out. Liver function and kidney tests continue periodically. Your team will tell you the specific schedule that applies to you.
Before any planned procedure
Ibrutinib is usually held for several days before any procedure that carries a bleeding risk. Tell your surgeon, dentist or anaesthetist you are taking it. Tell your oncology team before any procedure is booked.
If new symptoms appear between tests
Palpitations, unusual bruising, breathlessness or any symptom that worries you should prompt a call to your team rather than waiting for your next scheduled test.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
You do not have to work this out alone
A 45-minute consultation with a specialist who treats this every week.
What does each test check, and what should prompt a call?
| Test | When it is done | What it looks for | Tell your team if you notice |
|---|---|---|---|
| Complete blood count | Monthly at first, then periodically | Platelet count, neutrophils and haemoglobin | Easy bruising, bleeding that will not stop, extreme tiredness, or fever |
| Liver function (ALT, AST, bilirubin) | Every few months | Whether your liver is handling the drug normally | Yellowing of skin or eyes, nausea, or discomfort under your right ribcage |
| Kidney function (creatinine) | Periodically | Kidney health and hydration | Leg swelling, reduced urine output, or unusual thirst |
| Blood pressure | At every clinic visit | Ibrutinib can raise blood pressure gradually over time | Any home reading that concerns you, or persistent headaches |
| ECG | At baseline; repeated if symptoms occur | Heart rhythm — ibrutinib increases the risk of atrial fibrillation in a proportion of patients | Palpitations, racing heart, dizziness, or sudden breathlessness |
| Lymphocyte count (CLL patients) | Part of your regular blood count | A rise in the early months is an expected treatment effect, not progression | Ask your team before drawing any conclusions from a rising number |
Did you know?
In people being treated for CLL with ibrutinib, the lymphocyte count often rises sharply in the first weeks to months of treatment before falling. NCCN guidance describes this as treatment-related lymphocytosis — a sign the drug is redistributing cancer cells from lymph nodes into the blood, not a sign of disease progression.
If no one has explained this to you and you see a rising number on your blood test result, ask your team before drawing any conclusions.
Source: NCCN Clinical Practice Guidelines in Oncology: Chronic Lymphocytic Leukaemia / Small Lymphocytic Lymphoma
Explore 75 more Blood Cancer Targeted Medicines topics
Drug Deep Dive: Ibrutinib (Imbruvica)
- Diarrhoea, Joint Pain and Infection Risk on Ibrutinib
- Diet and Nutrition While on Ibrutinib
- Easy Bruising and Bleeding on Ibrutinib: What Is Normal and What Is Not
- Fertility, Pregnancy and Contraception on Ibrutinib
- How Does Ibrutinib Work? The BTK Inhibitor Explained
- How Long Does Ibrutinib Take to Work?
- How Long Will You Stay on Ibrutinib?
- Ibrutinib (Imbruvica, Ibrutix): The Complete Patient Guide
- Ibrutinib Interactions: Blood Thinners, Antifungals and Fish Oil
- Ibrutinib Myths: Lifelong Treatment, Bruising and 'It's Not Real Treatment'
- Ibrutinib Price in India: Brand, Generic and Monthly Cost
- Ibrutinib Side Effects: The Complete List and Timeline
- Ibrutinib Success Rate and Survival: An Honest Look at the Numbers
- Ibrutinib With Rituximab or Venetoclax: Continuous vs Fixed-Duration Therapy
- Ibrutinib in CLL, Mantle Cell Lymphoma and Waldenstrom's
- Ibrutinib in Elderly Patients and Those With Other Illnesses
- Ibrutinib vs Acalabrutinib vs Zanubrutinib: Comparing BTK Inhibitors
- Palpitations, Atrial Fibrillation and High Blood Pressure on Ibrutinib
- Surgery and Dental Procedures on Ibrutinib: The Bleeding Rule
- Taking Ibrutinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Ibrutinib
- When Ibrutinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Ibrutinib? CLL, Mantle Cell Lymphoma and Waldenstrom's Macroglobulinaemia
- Will Insurance or a Government Scheme Pay for Ibrutinib?
- Work, Travel and Daily Life on Ibrutinib
Drug Deep Dive: Imatinib (Gleevec)
- Adjuvant Imatinib After GIST Surgery: How Many Years?
- BCR-ABL PCR Monitoring: What 'Log Reduction' and 'MR4.5' Mean
- Can You Ever Stop Imatinib? Treatment-Free Remission Explained
- Diet and Nutrition While on Imatinib
- Fertility, Pregnancy and Contraception on Imatinib
- How Does Imatinib Work? The BCR-ABL and KIT Inhibitor Explained
- How Long Does Imatinib Take to Work?
- Imatinib (Gleevec, Veenat, Imatib): The Complete Patient Guide
- Imatinib Interactions: Paracetamol, Antacids and Herbal Medicines
- Imatinib Myths: Lifelong Dependence, Fertility and Generic Quality
- Imatinib Price in India: Brand, Generic and Monthly Cost
- Imatinib Side Effects: The Complete List and Timeline
- Imatinib Success Rate and Survival: An Honest Look at the Numbers
- Imatinib for GIST: How It Differs From CML Treatment
- Imatinib in Elderly Patients and Those With Other Illnesses
- Imatinib vs Nilotinib vs Dasatinib: Choosing a CML Drug
- Muscle Cramps and Bone Pain on Imatinib: What Actually Helps
- Nausea, Stomach Upset and Weight Gain on Imatinib
- Puffy Eyes and Swollen Legs on Imatinib: Managing Fluid Retention
- Taking Imatinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Imatinib
- When Imatinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Imatinib? Chronic Myeloid Leukaemia and GIST
- Will Insurance or a Government Scheme Pay for Imatinib?
- Work, Travel and Daily Life on Imatinib
Drug Deep Dive: Rituximab (MabThera)
- Diet and Nutrition While on Rituximab
- Drug, Food and Supplement Interactions With Rituximab
- Fertility, Pregnancy and Contraception on Rituximab
- Hepatitis B Reactivation and Rituximab: The Test You Must Not Skip
- How Does Rituximab Work? The Anti-CD20 Monoclonal Antibody Explained
- How Long Does Rituximab Take to Work?
- How Long Will You Stay on Rituximab?
- Low Antibodies and Repeated Infections After Rituximab
- MabThera vs Biosimilar Rituximab in India: Cost and Equivalence
- R-CHOP and Other Rituximab Combinations Explained
- Rituximab (MabThera, Ristova and biosimilars): The Complete Patient Guide
- Rituximab Infusion Day: Premedication, Duration and What to Expect
- Rituximab Infusion Reactions: Why the First Infusion Is Different
- Rituximab Maintenance: Two More Years of Infusions, and Why
- Rituximab Myths: Vaccines, Immunity and 'Permanent Damage'
- Rituximab Price in India: Innovator, Biosimilar and Cost Per Cycle
- Rituximab Side Effects: The Complete List and Timeline
- Rituximab Success Rate and Survival: An Honest Look at the Numbers
- Rituximab in Elderly Patients and Those With Other Illnesses
- Tests and Monitoring While You Are on Rituximab
- When Rituximab Stops Working: Resistance and What Comes Next
- Who Is Eligible for Rituximab? B-Cell Lymphoma and CLL
- Why the Same Drug Treats Arthritis and Lymphoma
- Will Insurance or a Government Scheme Pay for Rituximab?
- Work, Travel and Daily Life on Rituximab
Next step
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Common questions
Frequently asked questions
How long will I need to keep having these tests?
For as long as you are taking ibrutinib. Monitoring does not stop once you settle into the drug. Blood pressure tends to be watched throughout because it can rise gradually over many months, and the risk of atrial fibrillation continues for as long as you are on treatment. Your team will tell you if the frequency of any individual test changes, but routine monitoring continues throughout.
My lymphocyte count has gone up since I started ibrutinib. Does that mean the cancer is getting worse?
In most cases, no. A rise in lymphocytes is a well-recognised effect of ibrutinib in CLL — the drug dislodges cancer cells from lymph nodes into the blood before the immune system can clear them. NCCN guidance treats this as a treatment effect rather than progression, and it usually resolves over months of continued treatment. Your oncologist will look at the trend alongside your other results, not at a single number in isolation.
What is atrial fibrillation and how would I know if I have it?
Atrial fibrillation, or AF, is an irregular heart rhythm. You might notice your heart beating faster than usual, or feel as though it is fluttering or skipping. Some people feel suddenly dizzy or short of breath for no clear reason. Some feel nothing at all, which is why an ECG is done at baseline and repeated if any symptoms appear. If you notice any of these feelings, call your team the same day rather than waiting — AF is manageable when caught early.
Do I need to stop ibrutinib before a dental appointment or surgery?
Almost certainly yes for any procedure with a meaningful bleeding risk, but that decision belongs to your oncology team in discussion with whoever is doing the procedure — not to you alone. Do not stop ibrutinib without being told to. Tell your dentist, surgeon or anaesthetist you are on ibrutinib before any procedure is booked. Tell your oncology team about the procedure as early as possible so the timing can be planned safely.
Should I be checking my blood pressure at home?
It can genuinely help. Blood pressure changes on ibrutinib can develop gradually and feel like nothing. A home reading between clinic visits gives your team more information than a single clinic measurement. If you have a home device, take readings at the same time on several different days and bring the log to your next visit. Tell your team immediately if any reading concerns you rather than waiting for a scheduled appointment.